139 related articles for article (PubMed ID: 37424405)
21. HLA DQB1*0301 allele is involved in the susceptibility to erythema multiforme.
Khalil I; Lepage V; Douay C; Morin L; al-Daccak R; Wallach D; Binet O; Lemarchand F; Degos L; Hors J
J Invest Dermatol; 1991 Oct; 97(4):697-700. PubMed ID: 1940441
[TBL] [Abstract][Full Text] [Related]
22. Human leukocyte antigen-A, -B and -C alleles and human leukocyte antigen haplotypes in Turkey: relationship to other populations.
Uyar FA; Dorak MT; Saruhan-Direskeneli G
Tissue Antigens; 2004 Aug; 64(2):180-7. PubMed ID: 15245373
[TBL] [Abstract][Full Text] [Related]
23. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial.
Grothey A; Van Cutsem E; Sobrero A; Siena S; Falcone A; Ychou M; Humblet Y; Bouché O; Mineur L; Barone C; Adenis A; Tabernero J; Yoshino T; Lenz HJ; Goldberg RM; Sargent DJ; Cihon F; Cupit L; Wagner A; Laurent D;
Lancet; 2013 Jan; 381(9863):303-12. PubMed ID: 23177514
[TBL] [Abstract][Full Text] [Related]
24. Association of herpes simplex virus-induced erythema multiforme with the human leukocyte antigen DQw3.
Kämpgen E; Burg G; Wank R
Arch Dermatol; 1988 Sep; 124(9):1372-5. PubMed ID: 3415279
[TBL] [Abstract][Full Text] [Related]
25. Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial.
Eng C; Kim TW; Bendell J; Argilés G; Tebbutt NC; Di Bartolomeo M; Falcone A; Fakih M; Kozloff M; Segal NH; Sobrero A; Yan Y; Chang I; Uyei A; Roberts L; Ciardiello F;
Lancet Oncol; 2019 Jun; 20(6):849-861. PubMed ID: 31003911
[TBL] [Abstract][Full Text] [Related]
26. Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study.
Bekaii-Saab TS; Ou FS; Ahn DH; Boland PM; Ciombor KK; Heying EN; Dockter TJ; Jacobs NL; Pasche BC; Cleary JM; Meyers JP; Desnoyers RJ; McCune JS; Pedersen K; Barzi A; Chiorean EG; Sloan J; Lacouture ME; Lenz HJ; Grothey A
Lancet Oncol; 2019 Aug; 20(8):1070-1082. PubMed ID: 31262657
[TBL] [Abstract][Full Text] [Related]
27. Association between HLA-B*58:01 allele and severe cutaneous adverse reactions with allopurinol in Han Chinese in Hong Kong.
Chiu ML; Hu M; Ng MH; Yeung CK; Chan JC; Chang MM; Cheng SH; Li L; Tomlinson B
Br J Dermatol; 2012 Jul; 167(1):44-9. PubMed ID: 22348415
[TBL] [Abstract][Full Text] [Related]
28. Allele and haplotype frequencies of human leukocyte antigen-A, -B, -C, -DRB1, -DRB3/4/5, -DQA1, -DQB1, -DPA1, and -DPB1 by next generation sequencing-based typing in Koreans in South Korea.
Baek IC; Choi EJ; Shin DH; Kim HJ; Choi H; Kim TG
PLoS One; 2021; 16(6):e0253619. PubMed ID: 34153078
[TBL] [Abstract][Full Text] [Related]
29. Human Leukocyte Antigen Class I Genes Associated With Stevens-Johnson Syndrome and Severe Ocular Complications Following Use of Cold Medicine in a Brazilian Population.
Wakamatsu TH; Ueta M; Tokunaga K; Okada Y; Loureiro RR; Costa KA; Sallum JMF; Milhomens JA; Inoue C; Sotozono C; Gomes JÁP; Kinoshita S
JAMA Ophthalmol; 2017 Apr; 135(4):355-360. PubMed ID: 28278336
[TBL] [Abstract][Full Text] [Related]
30. Clinical management of regorafenib in the treatment of patients with advanced colorectal cancer.
Sastre J; Argilés G; Benavides M; Feliú J; García-Alfonso P; García-Carbonero R; Grávalos C; Guillén-Ponce C; Martínez-Villacampa M; Pericay C
Clin Transl Oncol; 2014 Nov; 16(11):942-53. PubMed ID: 25223744
[TBL] [Abstract][Full Text] [Related]
31. [Allelic and haplotypic diversity of HLA-A, -B, -C, and -DRB1 genes in Koreans defined by high-resolution DNA typing].
Chung HY; Yoon JA; Han BY; Song EY; Park MH
Korean J Lab Med; 2010 Dec; 30(6):685-96. PubMed ID: 21157157
[TBL] [Abstract][Full Text] [Related]
32. Determination of HLA-A, -C, -B, -DRB1 allele and haplotype frequency in Japanese population based on family study.
Ikeda N; Kojima H; Nishikawa M; Hayashi K; Futagami T; Tsujino T; Kusunoki Y; Fujii N; Suegami S; Miyazaki Y; Middleton D; Tanaka H; Saji H
Tissue Antigens; 2015 Apr; 85(4):252-9. PubMed ID: 25789826
[TBL] [Abstract][Full Text] [Related]
33. Regorafenib in Chinese patients with metastatic colorectal cancer: Subgroup analysis of the phase 3 CONCUR trial.
Xu J; Xu RH; Qin S; Pan H; Bai Y; Chi Y; Wang L; Bi F; Cheng Y; Liu T; Ma D; Shen L; Ba Y; Liang J; Wang X; Yau TCC; Ma BB; Yeh KH; Lin JK; Kappeler C; Shapiro J; Kalmus J; Li J
J Gastroenterol Hepatol; 2020 Aug; 35(8):1307-1316. PubMed ID: 31900959
[TBL] [Abstract][Full Text] [Related]
34. Erythema multiforme induced by sorafenib for metastatic renal cell carcinoma.
Ikeda M; Fujita T; Mii S; Tanabe K; Tabata K; Matsumoto K; Satoh T; Iwamura M
Jpn J Clin Oncol; 2012 Sep; 42(9):820-4. PubMed ID: 22782962
[TBL] [Abstract][Full Text] [Related]
35. HLA-A*02:01:01/-B*35:01:01/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients.
Fricke-Galindo I; Martínez-Juárez IE; Monroy-Jaramillo N; Jung-Cook H; Falfán-Valencia R; Ortega-Vázquez A; Alonso-Vilatela ME; López-López M
Pharmacogenomics; 2014; 15(15):1881-91. PubMed ID: 25495410
[TBL] [Abstract][Full Text] [Related]
36. A high-resolution genotyping method for HLA-C alleles and possible shared HLA-C-B haplotypes between Japanese and Caucasians.
Wang H; Tokunaga K; Ishikawa Y; Tanaka H; Kashiwase K; Shibata Y; Juji T
Tissue Antigens; 1997 Dec; 50(6):620-6. PubMed ID: 9458115
[TBL] [Abstract][Full Text] [Related]
37. Association of HLA-B*51:01 with papillary thyroid carcinoma in the Chinese Han population of the Shandong coastal areas.
Shuxian J; Xiaoyun C; Zhihui F; Xiaohua L; Zhanhui D; Bin H; Lin Z
Thyroid; 2014 May; 24(5):867-71. PubMed ID: 24308748
[TBL] [Abstract][Full Text] [Related]
38. Analysis of 250 HLA-B44 genotypes in European Caucasoids: high diversity and preferential ABCDRB1 associations in B*4402, B*4403, and B*4405 haplotypes.
Tiercy JM
Tissue Antigens; 2005 May; 65(5):429-36. PubMed ID: 15853897
[TBL] [Abstract][Full Text] [Related]
39. Behçet disease, new insights in disease associations and manifestations: a next-generation sequencing study.
Elfishawi M; Mossallam G; Augusto DG; Montero-Martin G; de Bruin H; Van de Pasch L; Norman PJ; Rozemuller E; Fernandez-Vina M; Abrudescu A; Hollenbach JA; Zaky K; Elfishawi S
Clin Exp Immunol; 2021 Apr; 204(1):144-151. PubMed ID: 33421092
[TBL] [Abstract][Full Text] [Related]
40. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
